Clinical Trial Update: A Trial to Compare Efficacy and Safety of Follitropin Delta Versus Placebo (Inactive Treatment) in the Treatment of Men With Idiopathic Infertility (Unexplained Reduction of Semen Quality) (ADAM) [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating follitropin delta versus placebo in men with idiopathic infertility has been terminated; no results are provided in this update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility
• Male Infertility

Drugs mentioned

• Follitropin Delta (follicle-stimulating hormone delta)

Snippet

Sponsor: Ferring Pharmaceuticals | Conditions: Male Idiopathic Infertility | Phase 2 | Status: TERMINATED